Similarly, the fact β-III−/− mice when administered verapamil even for a short period-of-time become lethargic suggests the broad action of this drug may preclude it from being a viable, chronic therapeutic option for cerebellar ataxias. This evidence concerns the gene PPIB and cerebellar ataxia.